Abstract
PURPOSE Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) show efficacy in treating patients with lung adenocarcinoma with EGF......
小提示:本篇文献需要登录阅读全文,点击跳转登录